HIV Citations List: September 2023
Literature Citations
1. Identification of Phytoconstituents from Albizia lebbeck as Potential Therapeutics against HIV-1 Reverse Transcriptase Associated with Infective Endocarditis: In Silico and in Vitro Approaches. Al-Masri, A.A. Saudi Journal of Biological Sciences, 2023. 30(9): 103751. PMID[37593463]. PMCID[PMC10428122].
[PubMed]. HIV_09_2023.
2. Cationic Chitosan Derivatives for the Inactivation of HIV-1 and SARS-CoV-2 Enveloped Viruses. Cele, Z.E.D., W. Matshe, L. Mdlalose, K. Setshedi, K. Malatji, N.P. Mkhwanazi, T. Ntombela, and M. Balogun. ACS Omega, 2023. 8(35): p. 31714-31724. PMID[37692209]. PMCID[PMC10483524].
[PubMed]. HIV_09_2023.
3. CDK8 Inhibitors Antagonize HIV-1 Reactivation and Promote Provirus Latency in T Cells. Horvath, R.M., Z.L. Brumme, and I. Sadowski. Journal of Virology, 2023. 97(9): e0092323. PMID[37671866]. PMCID[PMC10537590].
[PubMed]. HIV_09_2023.
4. Pronucleotides of 2',3'-dideoxy-2',3'-didehydrothymidine as Potent Anti-HIV Compounds. Jia, X., D. Schols, and C. Meier. Journal of Medicinal Chemistry, 2023. 66(17): p. 12163-12184. PMID[37647547].
[PubMed]. HIV_09_2023.
5. Peptide Bispecifics Inhibiting HIV-1 Infection by an Orthogonal Chemical and Supramolecular Strategy. Schauenburg, D., F. Zech, A.J. Heck, P. von Maltitz, M. Harms, S. Führer, N. Alleva, J. Münch, S.L. Kuan, F. Kirchhoff, and T. Weil. Bioconjugate Chemistry, 2023. 34(9): p. 1645-1652. PMID[37665137]. PMCID[PMC10515486].
[PubMed]. HIV_09_2023.
6. Novel HIV-1 RNA Biogenesis Inhibitors Identified by Virtual Pharmacophore-based Screening. Simba-Lahuasi, Á., J. Alcamí, M. Beltrán, L.M. Bedoya, and J. Gallego. Biochemical Pharmacology, 2023. 215: 115734. PMID[37549794].
[PubMed]. HIV_09_2023.
7. 5-Cyano substituted diarylpyridines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, and Activity Evaluation. Song, H., Y. Xia, T. Zhang, C. Dun, B. Meng, E. De Clercq, C. Pannecouque, D. Kang, P. Zhan, and X. Liu. European Journal of Medicinal Chemistry, 2023. 259: 115686. PMID[37536208].
[PubMed]. HIV_09_2023.
8. Dihydroxyphenyl- and Heteroaromatic-based thienopyrimidinones to Tackle HIV-1 LEDGF/P75-dependent IN Activity. Tocco, G., S. Canton, A. Laus, P. Caboni, S.F.J. Le Grice, E. Tramontano, and F. Esposito. Molecules, 2023. 28(18): p. 6700-6714. PMID[37764476]. PMCID[PMC10537185].
[PubMed]. HIV_09_2023.
9. Rational Design of Sulfonyl-γ-AApeptides as Highly Potent HIV-1 Fusion Inhibitors with Broad-spectrum Activity. Xue, S., W. Xu, L. Wang, L. Xu, L. Calcul, P. Teng, L. Lu, S. Jiang, and J. Cai. Journal of Medicinal Chemistry, 2023. 66(18): p. 13319-13331. PMID[37706450].
[PubMed]. HIV_09_2023.
10. Development of Novel Hept Analogs Featuring Significantly Improved Anti-resistance Potency against HIV-1 through Chemical Space Exploration of the Tolerant Region I. Zhou, R.L., C. Pannecouque, E. De Clercq, S. Wang, and F.E. Chen. Bioorganic Chemistry, 2023. 140: 106783. PMID[37595396].
[PubMed]. HIV_09_2023.
Patent Citations
This month, no relevant HIV patents were identified.